688238 Obio Technology
- 6.23
- +0.33+5.59%
Obio Technology News
Heyuan Biotech Investor Relations Activity Record List (October 24, 2024)
Heyuan Biotech: Report for the third quarter of 2024
Heyuan Biotech: Announcement on asset impairment preparations for the first three quarters of 2024
Heyuan Biotech: Announcement on holding the results briefing for the third quarter of 2024
Third Quarter Report 2024
Announcement on asset impairment preparations for the first three quarters of 2024
Announcement on holding the results briefing for the third quarter of 2024
Legal Opinion of Shanghai Jinmao Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Heyuan Biotechnology (Shanghai) Co., Ltd.
Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Heyuan Biotech: Haitong Securities Co., Ltd.\'s 2024 Semi-Annual Continuous Supervision and Follow-up Report on Heyuan Biotechnology (Shanghai) Co., Ltd.
Haitong Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Heyuan Biotechnology (Shanghai) Co., Ltd.
Heyuan Biotech Investor Relations Activity Record List (August 29, 2024)
Heyuan Biotech Investor Relations Activity Record Form (2024 Semi-Annual Results Briefing)
Announcement on the expiration of the shareholders\' holdings reduction plan and changes in equity of 1%
2024 Second Extraordinary General Meeting of Shareholders Meeting Materials
2024 Semi-Annual Report
2024 Semi-Annual Report Summary
Announcement on holding the 2024 semi-annual results briefing
Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Haitong Securities Co., Ltd. inspection opinions on the departure of directors, senior management and core technical personnel of Heyuan Biotechnology (Shanghai) Co., Ltd.
Analysis
Price Target
No Data
No Data